TotalMarketCap

Abbott Laboratories

ABTNYSE United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$196.991 B

$113.74 -1.53%

Close of 6 Nov 2026

As of 6 Nov 2026, Abbott Laboratories (ABT) has a market capitalization of $197.0B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$44.3B

#94 by revenue

Earnings

$6.52B

#80 by earnings

Shares outstanding

1,731,941,601

Latest filing cover page

P/E ratio

30.2

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #5NovartisNVS$309.0B
  2. #6AstrazenecaAZN$290.1B
  3. #7Abbott LaboratoriesABT$197.0B
  4. #8Novo Nordisk A SNVO$178.7B
  5. #9PfizerPFE$170.5B

What if Abbott Laboratories were worth as much as…

Open the what-if tool →

Gold $28.2T

$16,303.59

Per share 143× higher

Bitcoin $1.53T

$882.16

Per share 7.76× higher

Apple $5.02T

$2,896.05

Per share 25.5× higher

Or at a round number

$500.0B$1.00T$2.00T$5.00T

Where these numbers come from

Share counts and financials for Abbott Laboratories are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.